SCHEMBL2053383

SCHEMBL2053383

NC(=O)c1cc([N+](=O)[O-])n(C2CCC2)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
OPRM1 P35372 1/20 0.33
F10 P00742 2/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
CYP3A4 P08684 2/20 0.33
PIM1 P11309 2/20 0.32
PIM3 Q86V86 2/20 0.32
PIM2 Q9P1W9 2/20 0.32
CTPS1 P17812 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HCAR3 P49019 1/20 0.32
MAPT P10636 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
NR3C2 P08235 1/20 0.32
AR P10275 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2049998 0.94 SMN1; SMN2 (0.34) ALDH1A1F10SMN1; SMN2CYP3A4PIM1
SCHEMBL21960888 0.80 BAZ2B (0.39) ALDH1A1POLBMAPTHPGD
SCHEMBL27877217 0.77 OPRM1 (0.36) OPRM1F10PIM1PIM3PIM2
SCHEMBL4442669 0.76 L3MBTL1 (0.43) ALDH1A1OPRM1F10PIM1PIM3
SCHEMBL6611836 0.72 PLA2G10 (0.43) ALDH1A1SMN1; SMN2CYP3A4PKML3MBTL1
SCHEMBL23880197 0.71 OPRM1 (0.35) ALDH1A1OPRM1SMN1; SMN2PIM1PIM3
SCHEMBL27877237 0.70 F10 (0.37) ALDH1A1F10PIM1PIM3PIM2
SCHEMBL2794959 0.68 MAP3K14 (0.38) F10CYP3A4PIM1PIM3PIM2
SCHEMBL3500899 0.68 RXRA (0.36) ALDH1A1POLBGAAL3MBTL1HCAR3
SCHEMBL21961446 0.68 PTGS2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516444-A2 HETEROCYCLIC COMPOUNDS AS JANUS KINASE INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2012-10-31 EP disclosed
CN-102762571-A Heterocyclic compounds as janus kinase inhibitors BIOCRYST PHARM INC 2012-10-31 CN disclosed
WO-2011079230-A2 HETEROCYCLIC COMPOUNDS AS JANUS KINASE INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2011-06-30 WO disclosed